Cancel anytime
The Joint Corp (JYNT)JYNT
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: JYNT (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: 0.2% | Upturn Advisory Performance 2 | Avg. Invested days: 32 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: 0.2% | Avg. Invested days: 32 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 164.07M USD |
Price to earnings Ratio - | 1Y Target Price 16.38 |
Dividends yield (FY) - | Basic EPS (TTM) -1.14 |
Volume (30-day avg) 54065 | Beta 1.58 |
52 Weeks Range 8.60 - 17.82 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 164.07M USD | Price to earnings Ratio - | 1Y Target Price 16.38 |
Dividends yield (FY) - | Basic EPS (TTM) -1.14 | Volume (30-day avg) 54065 | Beta 1.58 |
52 Weeks Range 8.60 - 17.82 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-07 | When AfterMarket |
Estimate 0.01 | Actual -0.21 |
Report Date 2024-11-07 | When AfterMarket | Estimate 0.01 | Actual -0.21 |
Profitability
Profit Margin -13.95% | Operating Margin (TTM) 2.02% |
Management Effectiveness
Return on Assets (TTM) 2.01% | Return on Equity (TTM) -60.46% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 25.45 |
Enterprise Value 152757267 | Price to Sales(TTM) 1.36 |
Enterprise Value to Revenue 1.26 | Enterprise Value to EBITDA 21.11 |
Shares Outstanding 14983600 | Shares Floating 10741450 |
Percent Insiders 1.79 | Percent Institutions 73.22 |
Trailing PE - | Forward PE 25.45 | Enterprise Value 152757267 | Price to Sales(TTM) 1.36 |
Enterprise Value to Revenue 1.26 | Enterprise Value to EBITDA 21.11 | Shares Outstanding 14983600 | Shares Floating 10741450 |
Percent Insiders 1.79 | Percent Institutions 73.22 |
Analyst Ratings
Rating 4 | Target Price 19.88 | Buy 1 |
Strong Buy 2 | Hold 2 | Sell - |
Strong Sell - |
Rating 4 | Target Price 19.88 | Buy 1 | Strong Buy 2 |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
The Joint Corp.: A Comprehensive Overview
This report provides a comprehensive analysis of The Joint Corp. (JYNT), covering its history, products, market, financials, growth, competitors, and future potential.
Company Profile:
History and Background:
The Joint Corp. was founded in 1999 in Scottsdale, Arizona. It started as a single chiropractic clinic offering affordable and convenient chiropractic care. The company's franchising model began in 2002, and it has since grown to become the largest chiropractic franchise in the world. As of November 2023, The Joint has over 700 clinics across the United States.
Core Business Areas:
The Joint Corp. focuses on providing accessible and affordable chiropractic care through its network of franchised clinics. Its core business areas include:
- Chiropractic Adjustments: The Joint offers a variety of chiropractic adjustments to address various musculoskeletal conditions.
- Massage Therapy: The Joint also provides massage therapy services to help patients relax and manage pain.
- Other Wellness Services: The Joint offers additional wellness services such as nutritional counseling and injury prevention workshops.
Leadership Team and Corporate Structure:
The Joint Corp. is led by CEO Peter D. Holt, who has been with the company since 2010. The executive team also includes President and COO Peter J. Levesque and CFO Michael R. Lonergan. The company's corporate structure is based on a franchising model, with individual clinics owned and operated by franchisees.
Top Products and Market Share:
The Joint's primary product is chiropractic care, delivered through in-office adjustments. The company's market share in the U.S. chiropractic market is estimated to be around 10%. The company also offers massage therapy and other wellness services, which contribute to its overall market share.
Total Addressable Market:
The total addressable market for chiropractic care in the U.S. is estimated to be around $15 billion. The market is expected to grow steadily in the coming years, driven by factors such as an aging population and increasing awareness of the benefits of chiropractic care.
Financial Performance:
Recent Financial Statements:
The Joint Corp. reported revenue of $187.4 million for the fiscal year ended December 31, 2022. Net income was $17.2 million, with earnings per share of $0.46. The company's profit margin was 9.2%.
Year-over-Year Comparison:
The Joint Corp.'s revenue has grown steadily in recent years. In 2022, revenue increased by 12.4% compared to the previous year. Net income and earnings per share also increased year-over-year.
Cash Flow and Balance Sheet:
The Joint Corp. has a strong cash flow position, with operating cash flow of $30.4 million in 2022. The company's balance sheet is also healthy, with total assets of $227.5 million and total liabilities of $108.7 million.
Dividends and Shareholder Returns:
The Joint Corp. does not currently pay dividends. The company's total shareholder return over the past year was 12.5%.
Growth Trajectory:
Historical Growth:
The Joint Corp. has experienced strong historical growth. The company's revenue has grown at a compound annual growth rate (CAGR) of 15% over the past five years.
Future Growth Projections:
The Joint Corp. is expected to continue its growth trajectory in the coming years. The company's management team projects revenue growth of 10-15% in 2023.
Recent Initiatives:
The Joint Corp. is investing in several growth initiatives, including opening new clinics, expanding its service offerings, and developing new technology-based solutions.
Market Dynamics:
Industry Trends:
The chiropractic industry is expected to grow steadily in the coming years, driven by factors such as an aging population and increasing awareness of the benefits of chiropractic care.
Demand-Supply Scenario:
The demand for chiropractic care is expected to continue to increase in the coming years. However, the supply of qualified chiropractors is limited, which could create challenges for the industry.
Technological Advancements:
The chiropractic industry is increasingly adopting new technologies, such as telemedicine and wearable devices, to enhance patient care and improve efficiency.
The Joint Corp.'s Positioning:
The Joint Corp. is well-positioned to benefit from the growth of the chiropractic industry. The company's franchise model allows it to scale rapidly and open new clinics in new markets. The Joint also offers a convenient and affordable alternative to traditional chiropractic care, which makes it appealing to a wide range of consumers.
Competitors:
The Joint Corp.'s main competitors include:
- Chiropractic Health Center (CCHC): CCHC is a privately held company that operates over 300 chiropractic clinics in the United States.
- The Genesis Group: The Genesis Group is a publicly traded company that operates over 150 chiropractic clinics in the United States.
- ACU-Life: ACU-Life is a franchise-based chiropractic company that operates over 100 clinics in the United States.
Competitive Advantages and Disadvantages:
Advantages:
- Largest chiropractic franchise network in the U.S.
- Strong brand recognition:
- Convenient and affordable care:
- Technology-enabled platform:
Disadvantages:
- Limited service offerings compared to some competitors:
- Reliance on franchisees for growth:
- Exposure to regulatory changes in the healthcare industry:
Potential Challenges and Opportunities:
Challenges:
- Competition from other chiropractic providers:
- Rising healthcare costs:
- Changing consumer preferences:
Opportunities:
- Expansion into new markets:
- Development of new service offerings:
- Adoption of new technologies:
- Partnerships with other healthcare providers:
Recent Acquisitions:
The Joint Corp. has not made any acquisitions in the past three years.
AI-Based Fundamental Rating:
Rating: 7/10
The Joint Corp. receives a rating of 7/10 based on its strong financial performance, market position, and future growth prospects. The company's franchise model allows it to scale rapidly and open new clinics in new markets. The Joint also offers a convenient and affordable alternative to traditional chiropractic care, which makes it appealing to a wide range of consumers.
Sources and Disclaimers:
This report was prepared using information from the following sources:
- The Joint Corp. website
- The Joint Corp. annual report
- The Joint Corp. press releases
- Market research reports
This report is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.
Disclaimer:
The information provided in this report is based on publicly available information and should not be considered a substitute for professional financial advice. It is important to note that the stock market is volatile and past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About The Joint Corp
Exchange | NASDAQ | Headquaters | Scottsdale, AZ, United States |
IPO Launch date | 2014-11-11 | CEO, President & Director | Mr. Sanjiv Razdan |
Sector | Healthcare | Website | https://www.thejoint.com |
Industry | Medical Care Facilities | Full time employees | 444 |
Headquaters | Scottsdale, AZ, United States | ||
CEO, President & Director | Mr. Sanjiv Razdan | ||
Website | https://www.thejoint.com | ||
Website | https://www.thejoint.com | ||
Full time employees | 444 |
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.